Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
Front Aging Neurosci 2018;20:275-95
Med Sci Sports Exerc 16(4):328338 Qin Q-F, Liu M, Tian G-H, Chen J, Li Y-S (2018) Extract of the blood circulation-promoting recipe-84 can protect rat retinas by inhibiting the -catenin signaling pathway
With innovative tools, we give consumers more control over their own healthcare journeys and meet them where they are, supporting both consumers and their care teams
US$ 29.00
US$ 27.03
US$ 21.78
US$ 27.03
